HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Deals

Lilly plans new $4.5B manufacturing investment in Indiana

Eli Lilly is committing to its roots, allocating $4.5 billion for new manufacturing investments across Indiana as drugmakers pledge more US projects. The world’s largest pharma company, headquartered in Indianapolis,

By Endpoints News · May 6, 2026 · via Endpoints News
Lilly plans new $4.5B manufacturing investment in Indiana

Image: Endpoints News

This is an aggregated industry headline. Read the full story at Endpoints News →

Tags
dealsformat:headlineheadlineEndpoints News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Deals
All Deals →
Lilly, Gilead lead pharma’s M&A boom
DealsBioPharma Dive ↗
Lilly, Gilead lead pharma’s M&A boom
Deal volume in 2026 is substantially outpacing last year, and activity is being driven by interest in cancer a…
May 8, 2026
Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
DealsFiercePharma ↗
Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalys…
May 8, 2026
Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics
DealsFierceBiotech ↗
Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics
Roche is set to pay out a little more than $1 billion to acquire digital pathology specialist Path AI in a mov…
May 8, 2026